JoinClinicalTrials.com

• Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A

  NCT03520751

  Condition:   Charcot-Marie-Tooth Neuropathy Type 1A
  Intervention:   Drug: scAAV1.tMCK.NTF3
  Sponsor:   Nationwide Children's Hospital
  Not yet recruiting
• Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

  NCT01193088

  Conditions:   Charcot-Marie-Tooth Disease, Type Ia (Disorder);   HMSN
  Intervention:  
  Sponsors:   University of Iowa;   National Institute of Neurological Disorders and Stroke (NINDS);   Muscular Dystrophy Association;   University of Rochester;   University of Pennsylvania;   King's College Hospital NHS Trust;   Sydney Children's Hospitals Network;   Children's Hospital of Philadelphia;   University of Miami;   Johns Hopkins University;   University of Washington;   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta;   Cedars-Sinai Medical Center;   Nemours Children's Clinic;   Stanford University;   University of Michigan;   Vanderbilt University Medical Center
  Recruiting
• Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care

  NCT03715283

  Condition:   Charcot-Marie-Tooth Disease
  Interventions:   Other: Home Ankle Strengthing Program;   Other: Standard of Care
  Sponsor:   Ryan Castoro
  Recruiting
• Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy

  NCT03278093

  Conditions:   CMT - Charcot-Marie-Tooth Disease;   Peripheral Neuropathy;   Hereditary Peripheral Neuropathy;   CMT1A
  Intervention:  
  Sponsors:   St George's, University of London;   University College London Hospitals
  Recruiting